S&P ASX All Technology

3,804.20

-0.26%

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

QGEN Qiagen NV

44.52

-0.01 (-0.02%)

After Hours

Last Updated: 10:02:25

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Qiagen NV (NYSE:QGEN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Qiagen NV News

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
Friday 13 December 2024 (3 weeks ago) • Business Wire

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
Friday 6 December 2024 (4 weeks ago) • Business Wire

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
Thursday 28 November 2024 (1 month ago) • Business Wire

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Thursday 28 November 2024 (1 month ago) • GlobeNewswire Inc.

QIAGEN collaborates with McGill University to advance microbiome research
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Monday 4 November 2024 (2 months ago) • GlobeNewswire Inc.

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Tuesday 29 October 2024 (2 months ago) • GlobeNewswire Inc.

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
Friday 11 October 2024 (3 months ago) • GlobeNewswire Inc.

QIAGEN N.V. to release results for Q3 2024 and hold webcast
Thursday 10 October 2024 (3 months ago) • GlobeNewswire Inc.

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
Tuesday 8 October 2024 (3 months ago) • GlobeNewswire Inc.

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

QGEN Qiagen NV

Qiagen NV News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

QGEN Qiagen NV

Qiagen NV News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free